CMS Proposed Changes to 2027 Medicare Advantage Accounts Receivable (AR)

Medicare Advantage (MA) revenue for 2027 is being pushed toward a higher standard of proof, and revenue cycle leaders will need to respond. Across 2025 and 2026, the Centers for Medicare & Medicaid Services (CMS) made changes that tighten the connection between diagnoses, documented patient encounters, and risk-adjusted payment. CMS finalized the exclusion of diagnoses from unlinked chart review records for CY 2027, while it expanded the Risk Adjustment Data Validation (RADV) program to include every MA contract. 

Both changes directly impact the same point in the revenue cycle – the documentation supporting a diagnosis to a patient visit. 

For MA plans and physician groups, the issue is no longer limited to coding accuracy. Documentation quality can now influence RAF-driven revenue, audit exposure, risk-share reconciliation, and 2027 cash forecasts.

Below, we cover what CMS proposed in January, what it finalized in April, how the unlinked chart review exclusion and RADV expansion interact, and what revenue leaders should expect from a risk adjustment and AR partner as they close 2026.

Revenue cycle leaders at Medicare Advantage (MA) plans and physician groups who oversee risk adjustment, coding, and accounts receivable services now have fewer routes to navigate from diagnosis to payment. 

CMS published the CY 2027 Advance Notice on January 26, 2026, then finalized its policies in the CY 2027 Rate Announcement in April [1] [2]. The most significant change for revenue cycle leaders removes diagnoses tied to unlinked chart review records from risk score calculations, starting January 1, 2027.

The January proposal projected a 0.09% net average payment increase, worth more than $700 million to plans. It also called for recalibrating the MA risk adjustment model with current cost data and setting aside diagnoses with no link to a specific patient encounter. CMS anchored the proposal in three principles:

• Less paperwork for plans and providers
• Competition open to plans of every size
• Payments that track beneficiary health risk

The April Rate Announcement raised the projected increase to 2.48%, or more than $13 billion in added MA payments. 

CMS expects to see the largest payment impact on plans that relied heavily on retrospective, unlinked chart review. Physician groups in MA risk-share or capitated contracts will feel the same change through smaller RAF-driven settlements, documentation requests, and reconciliation activity from plan partners. Accounts receivable management services that forecast MA revenue will need to build that gap into 2027 cash projections.

The rule governs risk adjustment data and documentation, and it reaches every organization whose revenue depends on a risk score. 

For leaders focused on audit-ready revenue, the two exposures to watch are RAF leakage and audit failures. 

A condition may be clinically valid, but if the documentation and encounter data do not support the diagnosis in a risk-adjustment-eligible record, the expected revenue may not materialize.

That shifts more importance toward prospective and concurrent workflows. Teams need to identify documentation gaps while there is still an opportunity to address them within the appropriate clinical encounter rather than depending on retrospective cleanup later.

Teams running accounts receivable services for MA lines of business will see the effect first in delayed or reduced risk-share reconciliations, differences between projected and realized revenue, or increased follow-up with plan partners.

In other words, encounter documentation is becoming an AR forecasting issue as much as a coding and compliance issue.

Expanded RADV auditing increases the financial consequences of unsupported diagnoses.

In May 2025, CMS announced annual audits of every eligible MA contract, which means roughly 550 contracts each year instead of about 60, with up to 200 records reviewed per plan. For plans, each unsupported HCC now carries recoupment exposure [3]. 

For physician groups, that exposure shows up as medical-record requests and payment adjustments that strain accounts receivable management services, especially when AR, coding, and risk adjustment teams operate separately or are already short on staff. Paired with the 2027 unlinked chart review exclusion, plans and physician groups have less room to depend on retrospective processes to correct documentation gaps after the visit.

The practical implication is straightforward: organizations need to know not only which diagnoses were captured, but where the diagnosis came from, whether it is supported, and how it connects to expected revenue.

As organizations close 2026, prospective and concurrent capture should take a larger role in risk adjustment strategy rather than relying heavily on retrospective review.

When comparing accounts receivable companies or considering outsourcing accounts receivable, revenue leaders should look beyond collection activity alone.

The right partner should be able to connect:

• Encounter-linked diagnosis capture
• RAF and documentation visibility
• RADV readiness and AR forecasting

Medical billing and accounts receivable services providers with Medicare Advantage risk adjustment experience can help bring those workflows together.

3Gen Consulting’s hybrid approach (AI and human review), 100% chart review, RAF tracking, and submissions helps to turn encounter documentation into audit-ready revenue visibility. RiskGen-i combines AI with certified coder oversight at more than 97% HCC coding accuracy, applies MEAT and TAMPER validation before submission.

When comparing accounts receivable companies, physician groups should ask whether the team monitors encounter linkage, documentation gaps, and RADV exposure in the same workflow as its accounts receivable management services. That connection matters because AR teams should not discover a risk-adjustment revenue gap only when the expected payment fails to arrive.

Accounts receivable companies that also handle risk adjustment can connect RAF tracking to cash posting and reconciliation, so finance leaders see expected MA revenue before it arrives. 

At 3Gen Consulting, we help organizations pair outsourced accounts receivable with dedicated risk adjustment coding teams that scale for Q3-Q4 volume peaks. Accounts receivable services in the USA that connect these functions give payers and providers a clearer picture of 2027 revenue. To learn more about how we can support your team, contact us today.